← SynDRA
PIMOBENDAN
SynDRA canonical compound SYN0001466 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | PDE3A |
|---|
| Mechanism of action | Phosphodiesterase inhibitor |
|---|
| Indication | congestive heart failure |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- Calcium sensitizer
- Phosphodiesterase inhibitor
- calcium sensitizer, phosphodiesterase inhibitor
- PDE3B INHIBITOR
- PDE3A INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- NR1I2
- MAOA
- NPY1R
- HRH2
- HRH3
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MC3R
- MLNR
- ABCB11
- ADORA1
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE4D
- PGR
- PTGS2
- SLC6A2
- SLC6A3
- SLC6A4
- TBXA2R
- HRH1
- HDAC6
- GHSR
- ESR1
- ADORA2A
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AVPR1A
- AVPR2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- 5HT2A
- AHR
- ANDR
- CP1A2
- CREB1
- ESRRA
- GLI3
- KSYK
- NR1H4
- NSD2
- PRGR
- SYK
- TP53
- TSHR
Drug classes
- Cardiotonic Agents
- Cardiovascular Agents
- Enzyme Inhibitors
- Phosphodiesterase Inhibitors
- Protective Agents
- Vasodilator Agents
Cross-references
Synonyms
- Vetmedin
- UD-CG 115 BS
- UDCG 115
- acardi
- Pimobendane
- Acardi
- Dl-pimobendan
- Racemic pimobendan
- UD-CG-115
- UD-CG-115BS
- UDCG-115
- Pimobendan component of fortekor plus
- dl-Pimobendan
- pimobendan (usp monograph)
- pimobendan (usp-rs)
- UD-CG 115
- pimobendan (ep impurity)
- FORTEKOR PLUS COMPONENT PIMOBENDAN
- pimobendan (ema epar veterinary)
- pimobendane
- Pimobendanum
- CHEBI:32003
- UD-CG115
- Pimobendan,USP
- Vetmedin Solution
- Pimobendan EP5
- Vetmedin-CA1
- RefChem:55860
- SolutitionKits Pimobendan
- DTXCID9028255
- d-Pimobendan
- Pimobendan, (-)-
- (-)-Pimobendan
- l-Pimobendan
- (+)-Pimobendan
- Pimobendan, (+)-
- Pimobendan (Vetmedin)
- MFCD00761648
Look up PIMOBENDAN in the interactive SynDRA portal →